New Drug Approvals Slipped in 2010 - Wall Street Journal

New Drug Approvals Slipped in 2010 Wall Street Journal Roche Holding AG's biotechnology unit, Genentech, won approval for Actemra, a drug that's administered intravenously to treat rheumatoid arthritis. ... and more »

NASDAQ Hot Stocks to watch are - PNFP, CHTP, CETV, MAXY, IMMU - TapeBeat

NASDAQ Hot Stocks to watch are - PNFP, CHTP, CETV, MAXY, IMMU TapeBeat CTLA-4 Ig therapeutics for the treatment of a range of autoimmune disorders, including rheumatoid arthritis and transplant rejection. ...

2010 a mixed bag for biotech sector - San Diego Union Tribune

2010 a mixed bag for biotech sector San Diego Union Tribune Biogen Idec said it was shutting down cancer research in San Diego and shifting marketing for its cancer and rheumatoid arthritis drug Rituxan to a partner ... and more »

4SC Completes Enrolment of the Phase IIb COMPONENT Trial with Vidofludimus in ... - SunHerald.com

4SC Completes Enrolment of the Phase IIb COMPONENT Trial with Vidofludimus in ... SunHerald.com They differ from other groups of drugs used in the treatment of rheumatoid diseases, because they are able to stop or reduce damage caused from chronic ... and more »